CHA
PFE icon

Carmichael Hill & Associates’s Pfizer PFE Stock Holding History

Carmichael Hill & Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$574K Buy
19,850
+219
+1% +$6.39K 0.2% 90
2024
Q2 		$549K Buy
19,631
+17
+0.1% +$468 0.22% 82
2024
Q1 		$544K Buy
19,614
+2,500
+15% +$69.4K 0.22% 84
2023
Q4 		$493K Sell
17,114
-620
-3% -$18.7K 0.2% 88
2023
Q3 		$588K Buy
17,734
+558
+3% +$19.7K 0.27% 72
2023
Q2 		$630K Buy
17,176
+1,657
+11% +$64.5K 0.28% 73
2023
Q1 		$633K Buy
15,519
+518
+3% +$22.4K 0.31% 71
2022
Q4 		$769K Sell
15,001
-655
-4% -$31.4K 0.39% 59
2022
Q3 		$685K Buy
15,656
+105
+0.7% +$5.1K 0.37% 63
2022
Q2 		$815K Buy
15,551
+907
+6% +$46.2K 0.43% 54
2022
Q1 		$758K Sell
14,644
-438
-3% -$22.7K 0.35% 63
2021
Q4 		$891K Buy
15,082
+11
+0.1% +$545 0.4% 52
2021
Q3 		$648K Buy
15,071
+146
+1% +$6.47K 0.32% 66
2021
Q2 		$584K Buy
14,925
+157
+1% +$6.11K 0.3% 70
2021
Q1 		$535K Buy
14,768
+270
+2% +$9.59K 0.29% 74
2020
Q4 		$534K Sell
14,498
-637
-4% -$23.4K 0.31% 68
2020
Q3 		$527K Buy
15,135
+424
+3% +$14.9K 0.35% 59
2020
Q2 		$456K Buy
14,711
+580
+4% +$19.7K 0.34% 66
2020
Q1 		$438K Sell
14,131
-305
-2% -$10.4K 0.38% 58
2019
Q4 		$537K Buy
14,436
+693
+5% +$24.7K 0.38% 61
2019
Q3 		$468K Sell
13,743
-211
-2% -$7.67K 0.46% 60
2019
Q2 		$574K Sell
13,954
-240
-2% -$9.53K 0.57% 52
2019
Q1 		$572K Sell
14,194
-793
-5% -$31.8K 0.59% 49
2018
Q4 		$621K Sell
14,987
-1,007
-6% -$41.8K 0.71% 44
2018
Q3 		$669K Buy
15,994
+10
+0.1% +$385 0.65% 49
2018
Q2 		$550K Sell
15,984
-76
-0.5% -$2.6K 0.59% 52
2018
Q1 		$541K Sell
16,060
-881
-5% -$30.3K 0.59% 53
2017
Q4 		$582K Buy
+16,941
New +$578K 0.64% 49

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Carmichael Hill & Associates's PFE Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Pfizer (PFE) stake by 1.1% in Q3 2024, buying an estimated $6.39K and bringing the position to 19,850 shares worth $574K. The position accounts for 0.2% of the portfolio, ranked #90.

Carmichael Hill & Associates first reported a position in PFE in Q4 2017 and has held it in 28 quarters since. The position peaked at $891K in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Carmichael Hill & Associates held 19,850 shares of Pfizer worth $574K as of Q3 2024.
  • Carmichael Hill & Associates bought 219 Pfizer shares in Q3 2024, an estimated $6.39K.
  • Pfizer made up 0.2% of Carmichael Hill & Associates's portfolio in Q3 2024, its #90 holding.
  • Carmichael Hill & Associates first reported a position in Pfizer in Q4 2017 and has held it in 28 quarters since.
  • Carmichael Hill & Associates's Pfizer position peaked at $891K in Q4 2021.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.